ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RAJINDER CHHOKAR M.D.

2300 MANCHESTER EXPY STE 1001 BUTLER PAVILION

Columbus | Georgia | 31904

(706) 322-0528

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,646Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 439

$492K Total Retail Price of All Prescriptions

Rank: 74 out of 439

835 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 835 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 6,875 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
CARVEDILOL 401 374 1 8
CLOPIDOGREL 358 310 2 16
LISINOPRIL 329 277 3 4
ATENOLOL 326 286 4 24
PLAVIX 319 293 5 26
SIMVASTATIN 293 268 6 3
AMLODIPINE BESYLATE 289 277 7 2
WARFARIN SODIUM 223 213 8 10
FUROSEMIDE 204 194 9 5
PRAVASTATIN SODIUM 203 188 10 23
ATORVASTATIN CALCIUM 203 187 10 12
NITROSTAT 198 160 12 70
LOSARTAN POTASSIUM 192 183 13 31
METOPROLOL SUCCINATE 191 167 14 13
BENAZEPRIL HCL 177 134 15 130
CRESTOR 174 155 16 33
POTASSIUM CHLORIDE 137 130 17 30
HYDROCHLOROTHIAZIDE 129 115 18 18
DILTIAZEM 24HR ER 126 118 19 167
AMIODARONE HCL 120 113 20 94
ISOSORBIDE MONONITRATE ER 120 105 20 28
VYTORIN 114 114 22 227
DIOVAN 109 107 23 65
BISOPROLOL FUMARATE 103 77 24 133
PROPAFENONE HCL 103 103 24 206
NIASPAN 96 90 26 145
NITROGLYCERIN PATCH 87 73 27 132
DILTIAZEM 24HR CD 78 71 28 207
DILTIAZEM ER 78 77 28 182
RAMIPRIL 77 70 30 118
CARTIA XT 76 68 31 371
LOVAZA 74 62 32 266
FENOFIBRATE 73 70 33 131
TRILIPIX 62 45 34 264
PACERONE 61 52 35 281
RANEXA 60 46 36 166
BISOPROLOL-HYDROCHLOROTHIAZIDE 60 49 36 342
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 36 91
HYDRALAZINE HCL 56 55 39 55
KLOR-CON M20 56 47 39 77
NADOLOL 55 46 41 419
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.